GE HealthCare Technologies (NASDAQ:GEHC) Issues FY 2026 Earnings Guidance

GE HealthCare Technologies (NASDAQ:GEHC) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 4.800-5.000 for the period, compared to the consensus EPS estimate of 5.050. The company issued revenue guidance of -.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC traded up $1.22 during trading hours on Thursday, hitting $60.71. 7,018,551 shares of the company’s stock traded hands, compared to its average volume of 3,850,763. GE HealthCare Technologies has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The company’s fifty day simple moving average is $73.72 and its two-hundred day simple moving average is $77.64. The company has a market cap of $27.70 billion, a price-to-earnings ratio of 13.32, a price-to-earnings-growth ratio of 1.55 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.03 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies will post 5 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is 3.07%.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Morgan Stanley lifted their target price on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. BTIG Research decreased their price target on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday. Piper Sandler dropped their price target on GE HealthCare Technologies from $96.00 to $88.00 and set an “overweight” rating on the stock in a research note on Friday, April 17th. Bank of America upped their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research note on Monday, January 5th. Finally, Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Eight research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $83.14.

Trending Headlines about GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Revenue and top-line strength: Q1 sales came in above expectations and organic growth was positive (services, Pharma Diagnostics, Imaging and AVS contributed), showing demand resilience. Q1 Financial Results
• Positive Sentiment: Analysts still see upside: Wells Fargo cut its target to $75 but kept an “overweight” rating, and BTIG trimmed its target to $80 while maintaining a “buy”—both imply meaningful upside from current levels despite the reset. Analyst Notes
• Neutral Sentiment: Management actions: GE HealthCare announced executive and operating changes and will combine Imaging and AVS into an Advanced Imaging Solutions segment to improve execution and scale; these are strategic but will take time to affect margins. Operational Updates
• Neutral Sentiment: Full earnings disclosure available: The earnings call transcript provides detail on cost pressures, supply issues and integration plans for Intelerad—useful for modeling recovery timing. Earnings Call Transcript
• Negative Sentiment: EPS miss and margin pressure: GAAP EPS was $0.99 vs. consensus ~$1.07; net margin declined, which heightened near-term downside as investors focus on profitability. Earnings Miss
• Negative Sentiment: Guidance cut and inflationary headwinds: FY26 EPS guidance was trimmed to $4.80–5.00 (below consensus ~5.05) and management cited higher chip, oil and freight costs plus tariffs—this is the primary driver of the selloff. Guidance Cut
• Negative Sentiment: Market reaction: The guidance cut and margin risk triggered a sharp near-term drop in the stock and heightened concerns about execution/near-term inflation passthrough; some commentators frame this as a buying opportunity, but near-term volatility is likely. Market Reaction

Hedge Funds Weigh In On GE HealthCare Technologies

Institutional investors and hedge funds have recently bought and sold shares of the business. Transamerica Financial Advisors LLC lifted its position in shares of GE HealthCare Technologies by 331.6% in the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 262 shares in the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in GE HealthCare Technologies in the 4th quarter valued at approximately $34,000. Zions Bancorporation National Association UT lifted its position in GE HealthCare Technologies by 125.1% in the 4th quarter. Zions Bancorporation National Association UT now owns 412 shares of the company’s stock worth $34,000 after buying an additional 229 shares in the last quarter. Miller Capital Partners Inc. acquired a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $38,000. Finally, Palisade Asset Management LLC acquired a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at $41,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.